Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Nafarelin vs. hCG Injection for Ovulation Induction in NC-IVF
NCT04850261Phase 2Withdrawn
- Sponsor
- Insel Gruppe
- Start
- May 2021
- Primary completion
- Mar 2024
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of nafarelin in infertility, sponsored by Insel Gruppe. Planned start May 2021; status: withdrawn.
02
Drugs
nafarelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04850261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850261.